Key Market Indicators
Belgium’s export of diagnostic reagents is projected to decline, falling from approximately $647 million in 2023 to around $589 million by 2028. This represents an average annual decrease of 1.5%. The trend of declining exports has been ongoing since 2004, with an average yearly drop of 0.5%. In 2023, Belgium ranked 11th globally in diagnostic reagent exports. Canada surpassed Belgium with exports valued at about $647 million. Germany, the Netherlands, and the United Kingdom held the second, third, and fourth positions, respectively. On the import side, Belgium is expected to see growth. The country's diagnostic reagent imports are forecasted to rise from roughly $695 million in 2023 to about $741 million by 2028. This marks an average annual increase of 1%. Since 2004, Belgium's demand for diagnostic reagents has surged, growing by an average of 1.9% per year.
